➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Merck
Johnson and Johnson
Express Scripts
Mallinckrodt

Last Updated: July 14, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206229


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 206229 describes LILETTA, which is a drug marketed by Medicines360 and is included in one NDA. There is one patent protecting this drug. Additional details are available on the LILETTA profile page.

The generic ingredient in LILETTA is levonorgestrel. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for 206229
Tradename:LILETTA
Applicant:Medicines360
Ingredient:levonorgestrel
Patents:1
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 206229

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INTRAUTERINE DEVICE;INTRAUTERINEStrength52MG
Approval Date:Feb 26, 2015TE:RLD:No
Patent:  Start TrialPatent Expiration:Mar 22, 2034Product Flag?YSubstance Flag?Delist Request?
Patented Use:A METHOD FOR PREVENTION OF PREGNANCY

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Moodys
Dow
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.